Epalrestat is a carboxylic acid derivative and a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy, which is one of the most common long-term complications in patients with diabetes mellitus. Reference standards of Epalrestat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Epalrestat
Catalogue No.:PA 05 87000
CAS :
Molecular Formula : C15H13NO3S2
Molecular Weight : 319.40
Epalrestat (E, E)-Isomer
Catalogue No.:PA 05 87510
Molecular Weight : 319.4
Epalrestat (Z, Z)-Isomer
Catalogue No.:PA 05 87520
Epalrestat (JP 0069)
Catalogue No.:PA JP0069
Molecular Formula : NA
Molecular Weight : NA
Epalrestat (E, Z)-Isomer
Catalogue No.:PA 05 0871000
Molecular Weight : 319.39
Epalrestat Dimer
Catalogue No.:PA 05 0871001
Molecular Formula : C30H26N2O6S4
Molecular Weight : 638.79
(E,E)-Epalrestat Ethyl Ester
Catalogue No.:PA 05 0871002
Molecular Formula : C17H17NO3S2
Molecular Weight : 347.45
2-((E)-5-((E)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
Catalogue No.:PA 05 0871003
2-((Z)-5-((E)-2-methyl-3-(phenyl-d5)allylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
Catalogue No.:PA STI 088964
Molecular Formula : C15H8D5NO3S2
Molecular Weight : 324.42
(E)-2-methyl-3-(phenyl-2,3,4-d3)acrylaldehyde-d2
Catalogue No.:PA STI 088965
Molecular Formula : C10H5D5O
Molecular Weight : 151.22
3-Rhodanineacetic Acid
Catalogue No.:PA 05 0871004
Molecular Formula : C5H5NO3S2
Molecular Weight : 191.22
(2,4-Dioxo-thiazolidin-3-yl)acetic Acid
Catalogue No.:PA 05 0871005
Molecular Formula : C5H5NO4S
Molecular Weight : 175.16
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
